NCT00793052 is a NA clinical trial of Etodalac, Etoricoxib and Dexamethasone in Trismus, sponsored by Tel-Aviv Sourasky Medical Center.

Who is sponsoring NCT00793052?

NCT00793052 is sponsored by Tel-Aviv Sourasky Medical Center.

What drugs are being tested in NCT00793052?

Interventions in NCT00793052: Etodalac, Etoricoxib and Dexamethasone.

What condition does NCT00793052 study?

NCT00793052 studies Trismus, Edema, Pain.

Is NCT00793052 still recruiting?

NCT00793052 is currently status unknown. Last updated 16 November 2008.

Last reviewed 2008-11-16 · How we verify

NCT00793052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery: A Prospective, Double-Blind Study

Status unknown NA Last updated 16 November 2008

What this trial tests

NA trial testing Etodalac, Etoricoxib and Dexamethasone in Trismus in 80 participants. Status unknown.

Timeline

1 November 2008

Primary endpoint
1 December 2009

1 December 2009

Quick facts

Lead sponsor	Tel-Aviv Sourasky Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	triple
Primary purpose	treatment
Enrollment	80
Start date	1 November 2008
Primary completion	1 December 2009
Estimated completion	1 December 2009

Drugs / interventions tested

Etodalac, Etoricoxib and Dexamethasone — full drug profile →

Conditions studied

Trismus — all drugs for Trismus →
Edema — all drugs for Edema →
Pain — all drugs for Pain →

Sponsor

Tel-Aviv Sourasky Medical Center

Who can join

18 and older, any sex, with Trismus or Edema. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

PAIN- By VAS graded from 1-10 TRISMUS- By MAX mouth opening from the first incisors adages POST OPERATIVE SWELLing - By measurement the distance between the Right and LEFT ear's tragus
Time frame: 1 week

Sponsor's own description

The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Trismus

Currently open trials in the same condition.

NCT07450638 — Effect of Preoperative Long-Acting Corticosteroids on Pain, Swelling, and Trismus After Impacted Lower Third Molar Surge · NA · active not recruiting
NCT07244029 — Aescin-Based Herbal Extract (Reparil) for Postoperative Sequelae After Mandibular Third Molar Surgery · NA · recruiting
NCT07180498 — Evaluation of the Effect of Tea Tree and Chlorhexidine Mouthwashes on Healing After Third Molar Extraction · NA · recruiting
NCT06531083 — Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus · NA · recruiting
NCT06734598 — Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy · Phase 4 · recruiting

Other Tel-Aviv Sourasky Medical Center trials

Trials by the same sponsor.

NCT07380737 — Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot · NA · recruiting
NCT07104136 — Improving Adherence to COPD Treatments in Primary Care · NA · enrolling by invitation
NCT07327021 — MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC · Phase 2 · recruiting
NCT07191249 — A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previousl · Phase 2 · not yet recruiting
NCT07235332 — Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel. · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00793052 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tel-Aviv Sourasky Medical Center
Last refreshed: 16 November 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00793052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing